SEONG, JAE YOUNG,HWANG, JONG IK,SUN, WOONG,CHO, EUN BEE,KIM, WON-KI
申请号:
EP13748791
公开号:
EP2815769A4
申请日:
2013.02.15
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.